Director of Shandong Cancer Hospital and Institute
Latest Information Update: 14 Dec 2022
Price :
$35 *
At a glance
- Drugs Retlirafusp alfa (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 24 Sep 2020 New trial record
Latest Information Update: 14 Dec 2022